1081. Pauwels P, Sciot R, Croiset F, Rutten H, Van den Berghe H, Dal Cin P (2000). Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol. 191(3):282–5. PMID:10878550

1082. Pedersen L, Holck S, Mouridsen HT, Schødt T, Zedeler K (1999). Prognostic comparison of three classifications for medullary carcinoma of the breast. Histopathology. 34(2):175–8. PMID:10064398

1083. Peintinger F, Leibl S, Reitsamer R, Moinfar F (2004). Primary acinic cell carcinoma of the breast: a case report with long-term follow-up and review of the literature. Histopathology. 45(6):645–8. PMID:15569060

1084. Peiro G, Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, Nixon AJ, et al. (2000). The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 59(1):49–54. PMID:10752679

1085. Peltomäki P, Aaltonen LA, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, et al. (1993). Genetic mapping of a locus predisposing to human colorectal cancer. Science. 260(5109):810–2. PMID:8484120

1086. Peltomäki P, Vasen H (2004). Mutations associated with HNPCC predisposition – Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers. 20(4-5):269–76. PMID:15528792

1087. Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, et al. (2011). RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet. 20(16):3278–88. PMID:21616938

1087A. Penault-Llorca F, Bilous M, Dowsett M, Hanna W, Osamura RY, Rüschoff J, et al. (2009). Emerging technologies for assessing HER2 amplification. Am J Clin Pathol. 132(4):539–48. PMID:19762531

1088. Penner CG, Murphy LC, Huzel NJ, Yamada EW (1991). Antigenic reactivity of ribosomal protein S6 and the calcium-binding ATPase inhibitor protein of mammalian mitochondria. Mol Cell Biochem. 108(1):57–66. PMID:1837589

1089. Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, et al. (1995). Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology. 27(3):219–26. PMID:8522285

1089A. Perou CM, Parker JS, Prat A, Ellis MJ, Bernard PS (2010). Clinical implementation of the intrinsic subtypes of breast cancer. Lancet Oncol. 11(8):718–9, author reply 720–1. PMID:20688274

1090. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. (2000). Molecular portraits of human breast tumours. Nature. 406(6797):747–52. PMID:10963602

1091. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L (2008). European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol 19: 614–622.

1092. Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G (2009). Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 106(44):18740–4. PMID:19841262

1093. Perzin KH, Lattes R (1972). Papillary adenoma of the nipple (florid papillomatosis, adenoma, adenomatosis). A clinicopathologic study. Cancer. 29(4):996–1009. PMID:4335982

1094. Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, et al.; International Breast Cancer Study Group (2008). Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol. 26(18):3006–14. PMID:18458044

1095. Peters GN, Wolff M (1983). Adenoid cystic carcinoma of the breast. Report of 11 new cases: review of the literature and discussion of biological behavior. Cancer. 52(4):680–6. PMID:6305483

1096. Peters GN, Wolff M, Haagensen CD (1981). Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases. Ann Surg. 193(2):138–49. PMID:7469549

1097. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 28(6):622–9. PMID:17311302

1098. Pettigrew CA, French JD, Saunus JM, Edwards SL, Sauer AV, Smart CE, et al. (2010). Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1. Breast Cancer Res Treat. 119(1):239–47. PMID:19067158

1099. Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G (2004). Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol. 121(6):857–66. PMID:15198358

1100. Pettinato G, Manivel JC, Kelly DR, Wold LE, Dehner LP (1989). Lesions of the breast in children exclusive of typical fibroadenoma and gynecomastia. A clinicopathologic study of 113 cases. Pathol Annu. 24(Pt 2):296–328. PMID:2771454

1100A. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K (2007). Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 14(1):166–73. PMID:17066230

1101. Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008). Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 358(26):2796–803. PMID:18579814

1102. Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA; SEARCH Investigators (2007). Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet. 3(3):e42. [Abstract] PMID:17367212

1103. Phillipson J, Ostrzega N (1994). Fine needle aspiration of invasive cribriform carcinoma with benign osteoclast-like giant cells of histiocytic origin. A case report. Acta Cytol. 38(3):479–82. PMID:8191846

1104. Pia-Foschini M, Reis-Filho JS, Eusebi V, Lakhani SR (2003). Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol. 56(7):497–506. PMID:12835294

1105. Pierga JY, Mouret E, Laurence V, Diéras V, Savigioni A, Beuzeboc P, et al. (2003). Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response. Eur J Cancer. 39(8):1089–96. PMID:12736108

1106. Pina L, Apesteguía L, Cojo R, Cojo F, Arias-Camisón I, Rezola R, et al. (1997). Myofibroblastoma of male breast: report of three cases and review of the literature. Eur Radiol. 7(6):931–4. PMID:9228111

1107. Pinder SE, Duggan C, Ellis IO, Cuzick J, Forbes JF, Bishop H, et al.; UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma In Situ (DCIS) Working Party (2010). A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer. 103(1):94–100. PMID:20517310

1108. Pinder SE, Ellis IO, Galea M, O’Rouke S, Blamey RW, Elston CW (1994). Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 24(1):41–7. PMID:8144141

1109. Pinder SE, Provenzano E, Earl H, Ellis IO (2007). Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology. 50(4):409–17. PMID:17448015

1110. Pinder SE, Reis-Filho JS (2007). Non-operative breast pathology: columnar cell lesions. J Clin Pathol. 60(12):1307–12. PMID:17182657

1111. Pinilla SM, Honrado E, Hardisson D, Benítez J, Palacios J (2006). Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat. 99(1):85–90. PMID:16541313

1111A. Pitts WC, Rojas VA, Gaffey MJ, Rouse RV, Esteban J, Frierson HF, et al. (1991). Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol. 95(5):623–32. PMID:1850949

1112. Planchon SM, Waite KA, Eng C (2008). The nuclear affairs of PTEN. J Cell Sci. 121(Pt 3):249–53. PMID:18216329

1113. Pluquet O, Hainaut P (2001). Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett. 174(1):1–15. PMID:11675147

1113A. Podetta M, D’Ambrosio G, Ferrari A, Sgarella A, Dal Bello B, Fossati GS, et al. (2009). Low-grade fibromatosis-like spindle cell metaplastic carcinoma: a basal-like tumor with a favorable clinical outcome. Report of two cases. Tumori. 95(2):264–7. PMID:19579879

1114. Polednak AP (2003). Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery. 133(4):383–9. PMID:12717355

1115. Polyak K (2010). Molecular markers for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010(41):210–3. PMID:20956832

1116. Popnikolov NK, Ayala AG, Graves K, Gatalica Z (2003). Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas. Am J Clin Pathol. 120(2):161–7. PMID:12931544

1117. Porter PL, Garcia R, Moe R, Corwin DJ, Gown AM (1991). C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia. Cancer. 68(2):331–4. PMID:1676930

1118. Powell CM, Cranor ML, Rosen PP (1995). Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol. 19(3):270–7. PMID:7872425

1119. Powell CM, Rosen PP (1994). Adipose differentiation in cystosarcoma phyllodes. A study of 14 cases. Am J Surg Pathol. 18(7):720–7. PMID:8017566

1120. Prasad ML, Osborne MP, Giri DD, Hoda SA (2000). Microinvasive carcinoma (T1mic) of the breast: clinicopathologic profile of 21 cases. Am J Surg Pathol. 24(3):422–8. PMID:10716157

1121. Prasad SN, Houserkova D, Svach I, Zlamalova N, Kucerova L, Cwiertka K (2008). Pseudoangiomatous stromal hyperplasia of breast: a case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 152(1):117–20. PMID:18795085

1122. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12(5):R68. PMID:20813035

1123. Prat A, Perou CM (2011). Deconstructing the molecular portraits of breast cancer. Mol Oncol. 5(1):5–23. PMID:21147047

1124. Prescott RJ, Eyden BP, Reeve NL (1992). Sebaceous differentiation in a breast carcinoma with ductal, myoepithelial and squamous elements. Histopathology. 21(2):181–4. PMID:1324221

1125. Pugliese M, Stempel M, Patil S, Hsu M, Ho A, Traina T, et al. (2010). The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer. Am J Surg. 200(3):368–73. PMID:20800716

1126. Pugliese MS, Stempel MM, Cody HS 3rd, Morrow M, Gemignani ML (2009). Surgical management of the axilla: do intramammary nodes matter? Am J Surg. 198(4):532–7. PMID:19800463

1126A. Pusztai L, Mazouni C, Anderson K, Wu Y, Symmans WF (2006). Molecular classification of breast cancer: limitations and potential. Oncologist. 11(8):868–77. PMID:16951390

1127. Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, et al. (2002). HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer. 95(10):2068–75. PMID:12412159

1128. Quincey C, Raitt N, Bell J, Ellis IO (1991). Intracytoplasmic lumina–a useful diagnostic feature of adenocarcinomas. Histopathology. 19(1):83–7. PMID:1916690

1129. Rabban JT, Koerner FC, Lerwill MF (2006). Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum Pathol. 37(7):787–93. PMID:16784976

1130. Radhi JM (2000). Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR. Histopathology. 36(2):156–60. PMID:10672061

1131. Ragazzi M, de Biase D, Betts CM, Farnedi A, Ramadan SS, Tallini G, et al. (2011). Oncocytic carcinoma of the breast: frequency, morphology and follow-up. Hum Pathol. 42(2):166–75. PMID:21111455

1132. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al.; Breast Cancer Susceptibility Collaboration (UK) (2007). PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 39(2):165–7. PMID:17200668

1133. Rajan JV, Wang M, Marquis ST, Chodosh LA (1996). Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A. 93(23):13078–83. PMID:8917547

1134. Raju GC, O’Reilly AP (1987). Immunohistochemical study of granular cell tumour. Pathology. 19(4):402–6. PMID:2832806

1135. Rakha EA, Aleskandarany M, El-Sayed ME, Blamey RW, Elston CW, Ellis IO, et al. (2009). The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer. 45(10):1780–7. PMID:19286369

1135A. Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO (2005). High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. Int J Cancer. 114(5):720–9. PMID:15609312

1136. Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, et al. (2008). Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 26(19):3153–8. PMID:18490649

1137. Rakha EA, El-Sayed ME, Menon S, Green AR, Lee AH, Ellis IO (2008). Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 111(1):121–7. PMID:17929165

1138. Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, et al. (2008). Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer. 44(1):73–83. PMID:18035533

1139. Rakha EA, El-Sayed ME, Reed J, Lee AH, Evans AJ, Ellis IO (2009). Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis). Eur J Cancer. 45(7):1162–7. PMID:19121932

1140. Rakha EA, Gandhi N, Climent F, van Deurzen CH, Haider SA, Dunk L, et al. (2011). Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis. Am J Surg Pathol. 35(8):1093–103. PMID:21753694

1141. Rakha EA, Lee AH, Evans AJ, Menon S, Assad NY, Hodi Z, et al. (2010). Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol. 28(1):99–104. PMID:19917872

1142. Rakha EA, Lee AH, Jenkins JA, Murphy AE, Hamilton LJ, Ellis IO (2011). Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer. 129(6):1417–24. PMID:21128240

1143. Rakha EA, Lee AH, Reed J, Murphy A, El-Sayed M, Burrell H, et al. (2010). Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. Eur J Cancer. 46(10):1835–40. PMID:20392631

1144. Rakha EA, Patel A, Powe DG, Benhasouna A, Green AR, Lambros MB, et al. (2010). Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol. 34(10):1472–9. PMID:20871222

1145. Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, et al. (2006). Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol. 208(4):495–506. PMID:16429394

1146. Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, et al. (2010). Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res. 12(4):207. PMID:20804570

1147. Rakha EA, Reis-Filho JS, Ellis IO (2008). Basal-like breast cancer: a critical review. J Clin Oncol. 26(15):2568–81.http://dx.doi.org/10.1200/JCO.2007.13.1748 PMID:18487574

1148. Ramachandra S, Machin L, Ashley S, Monaghan P, Gusterson BA (1990). Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma–a detailed morphological analysis. J Pathol. 161(1):7–14. PMID:1973459

1149. Ramaswamy PV, Storm CA, Filiano JJ, Dinulos JG (2010). Multiple granular cell tumors in a child with Noonan syndrome. Pediatr Dermatol. 27(2):209–11. PMID:20537083

1150. Ramljak V, Sarcević B, Vrdoljak DV, Kelcec IB, Agai M, Ostović KT (2010). Fine needle aspiration cytology in diagnosing rare breast carcinoma–two case reports. Coll Antropol. 34(1):201–5. PMID:20432752

1151. Rammeh-Rommani S, Mrad K, Dhouib R, Sassi S, Driss M, Khattech R, et al. (2000). [Adenomyoepithelioma of the breast: two cases]. Ann Pathol. 20(4):365–8. PMID:11015657

1152. Ramos CV, Taylor HB (1974). Lipid-rich carcinoma of the breast. A clinicopathologic analysis of 13 examples. Cancer. 33(3):812–9. PMID:4815583

1153. Rao P, Shousha S (2010). Male nipple adenoma with DCIS followed 9 years later by invasive carcinoma. Breast J. 16(3):317–8. PMID:20408826

1154. Rao VK, Weiss SW (1992). Angiomatosis of soft tissue. An analysis of the histologic features and clinical outcome in 51 cases. Am J Surg Pathol. 16(8):764–71. PMID:1497117

1155. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR (1993). Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol. 169(2):245–50. PMID:8383197

1156. Rasbridge SA, Millis RR (1998). Adenomyoepithelioma of the breast with malignant features. Virchows Arch. 432(2):123–30. PMID:9504856

1157. Rasmussen BB, Rose C, Thorpe SM, Andersen KW, Hou-Jensen K (1985). Argyrophilic cells in 202 human mucinous breast carcinomas. Relation to histopathologic and clinical factors. Am J Clin Pathol. 84(6):737–40. [Abstract] PMID:2416216

1158. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, et al. (2001). Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 19(4):980–91. PMID:11181660

1159. Rawal A, Finn WG, Schnitzer B, Valdez R (2007). Site-specific morphologic differences in extranodal marginal zone B-cell lymphomas. Arch Pathol Lab Med. 131(11):1673–8. PMID:17979485

1160. Reardon W, Zhou XP, Eng C (2001). A novel germline mutation of the PTEN gene in a patient with macrocephaly, ventricular dilatation, and features of VATER association. J Med Genet. 38(12):820–3. PMID:11748304

1161. Recine MA, Deavers MT, Middleton LP, Silva EG, Malpica A (2004). Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 28(12):1646–51. PMID:15577686

1162. Reeves GK, Beral V, Green J, Gathani T, Bull D; Million Women Study Collaborators (2006). Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 7(11):910–8. PMID:17081916

1163. Reeves GK, Pirie K, Green J, Bull D, Beral V; Million Women Study Collaborators (2009). Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer. 100(3):538–44. PMID:19190634

1164. Regitnig P, Ploner F, Maderbacher M, Lax SF (2004). Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. Mod Pathol. 17(5):597–602. PMID:15017434

1165. Reis-Filho JS, Fulford LG, Crebassa B, Carpentier S, Lakhani SR (2004). Collagenous spherulosis in an adenomyoepithelioma of the breast. J Clin Pathol. 57(1):83–6. PMID:14693844

1166. Reis-Filho JS, Fulford LG, Lakhani SR, Schmitt FC (2003). Pathologic quiz case: a 62-year-old woman with a 4.5-cm nodule in the right breast. Lipid-rich breast carcinoma. Arch Pathol Lab Med. 127(9):e396–8. PMID:12951994

1167. Reis-Filho JS, Lakhani SR (2003). The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res. 5(6):313–9. PMID:14580249

1168. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC (2003). Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Cancer. 99(3):172–9. PMID:12811858

1168A. Reis-Filho JS, Milanezi F, Carvalho S, Simpson PT, Steele D, Savage K, et al. (2005). Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis. Breast Cancer Res. 7(6):R1028–35. PMID:16280056

1168B. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, et al. (2003). Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol. 11(1):1–8. PMID:12610349

1169. Reis-Filho JS, Milanezi F, Silva P, Schmitt FC (2001). Maspin expression in myoepithelial tumors of the breast. Pathol Res Pract. 197(12):817–21. PMID:11795829

1169A. Reis-Filho JS, Natrajan R, Vatcheva R, Lambros MB, Marchió C, Mahler-Araújo B, et al. (2008). Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6’split apart’ probes. Histopathology. 52(7):840–6. PMID:18462362

1170. Reis-Filho JS, Natrajan R, Vatcheva R, Lambros MB, Marchió C, Mahler-Araújo B, et al. (2008). Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6’split apart’ probes. Histopathology. 52(7):840–6.http://dx.doi.org/10.1111/j.1365-2559.2008.03046.x PMID:18462362

1170A. Reis-Filho JS, Pinheiro C, Lambros MB, Milanezi F, Carvalho S, Savage K, et al. (2006). EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol. 209(4):445–53. PMID:16739104

1171. Reis-Filho JS, Schmitt FC (2002). Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol. 9(5):280–9. PMID:12195217

1171A. Reis-Filho JS, Schmitt FC (2003). p63 expression in sarcomatoid/metaplastic carcinomas of the breast. Histopathology. 42(1):94–5. PMID:12493033

1172. Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, et al. (2005). Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol. 207(1):1–13. PMID:15957152

1173. Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C, Mackay A, et al. (2006). FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res. 12(22):6652–62. PMID:17121884

1173A. Reis-Filho JS, Weigelt B, Fumagalli D, Sotiriou C (2010). Molecular profiling: moving away from tumor philately. Sci Transl Med. 2(47):47ps43. PMID:20811040

1173B. Rekhi B, Shet TM, Badwe RA, Chinoy RF (2007). Fibromatosis-like carcinoma-an unusual phenotype of a metaplastic breast tumor associated with a micropapilloma. World J Surg Oncol. 5:24. PMID:17324295

1174. Renehan AG, Harvie M, Howell A (2006). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer. 13(2):273–8. PMID:16728563

1175. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, et al.; Breast Cancer Susceptibility Collaboration (UK) (2006). ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 38(8):873–5. PMID:16832357

1176. Requena L, Kutzner H, Mentzel T, Durán R, Rodríguez-Peralto JL (2002). Benign vascular proliferations in irradiated skin. Am J Surg Pathol. 26(3):328–37. PMID:11859204

1176A. Resetkova E, Albarracin C, Sneige N (2006). Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature. Am J Surg Pathol. 30(1):20–7. PMID:16330938

1177. Resetkova E, Flanders DJ, Rosen PP (2003). Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservation. Arch Pathol Lab Med. 127(1):77–80. PMID:12521372

1177A. Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, Kok M, et al. (2008). A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res. 10(6):R93. PMID:19014521

1178. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. (2004). Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A. 101(25):9309–14. PMID:15184677

1179. Ribeiro RC, Saltz R, España Quintera LF (2008). Breast reconstruction with parenchymal cross after giant lipoma removal. Aesthetic Plast Surg. 32(4):695–7. PMID:18498011

1180. Ribrag V, Bibeau F, El Weshi A, Frayfer J, Fadel C, Cebotaru C, et al. (2001). Primary breast lymphoma: a report of 20 cases. Br J Haematol. 115(2):253–6. PMID:11703318

1181. Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, et al. (1994). Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 171(1):171–7. PMID:8030695

1182. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, et al. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell. 9(2):121–32. PMID:16473279

1183. Rickert CH, Paulus W (2002). Genetic characterisation of granular cell tumours. Acta Neuropathol. 103(4):309–12. PMID:11904749

1184. Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V (1977). Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer. 40(4):1365–85. PMID:907958

1185. Riegert-Johnson DL, Gleeson FC, Roberts M, Tholen K, Youngborg L, Bullock M, et al. (2010). Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract. 8(1):6. [Abstract] PMID:20565722

1186. Riener MO, Nikolopoulos E, Herr A, Wild PJ, Hausmann M, Wiech T, et al. (2008). Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q. Hum Pathol. 39(11):1621–9. PMID:18656243

1187. Righi L, Sapino A, Marchiò C, Papotti M, Bussolati G (2010). Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. Semin Diagn Pathol. 27(1):69–76. PMID:20306832

1188. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, et al. (2006). Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 98(23):1694–706. PMID:17148771

1189. Rissanen T, Tikkakoski T, Autio AL, Apaja-Sarkkinen M (1998). Ultrasonography of invasive lobular breast carcinoma. Acta Radiol. 39(3):285–91. PMID:9571945

1190. Ro JY, Silva EG, Gallager HS (1987). Adenoid cystic carcinoma of the breast. Hum Pathol. 18(12):1276–81. PMID:2824330

1191. Roa BB, Boyd AA, Volcik K, Richards CS (1996). Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 14(2):185–7. PMID:8841191

1192. Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, et al. (2010). Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin. 60(6):351–75. PMID:20959401

1192A. Robertson FM, Petricoin EF, Chu K, Jin J, Circo R, Fernandez SV, et al. (2011). Amplification of anaplastic lymphoma kinase (ALK) as a common genetic alteration in inflammatory breast cancer. San Antonio Breast Cancer Symposium 2011, P3-01-18. Abstract.

1193. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A (2008). Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 21(4):455–63. PMID:18223553

1194. Rodríguez-Pinilla SM, Rodríguez-Gil Y, Moreno-Bueno G, Sarrió D, Martín-Guijarro MdelC, Hernandez L, et al. (2007). Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study. Am J Surg Pathol. 31(4):501–8. PMID:17414096

1195. Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, et al. (2009). T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res. 11(2):R15. PMID:19272155

1196. Rogers DA, Lobe TE, Rao BN, Fleming ID, Schropp KP, Pratt AS, et al. (1994). Breast malignancy in children. J Pediatr Surg. 29(1):48–51. PMID:8120761

1197. Rohen C, Caselitz J, Stern C, Wanschura S, Schoenmakers EF, Van de Ven WJ, et al. (1995). A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization. Cancer Genet Cytogenet. 84(1):82–4. PMID:7497449

1198. Roncaroli F, Lamovec J, Zidar A, Eusebi V (1996). Acinic cell-like carcinoma of the breast. Virchows Arch. 429(1):69–74. PMID:8865856

1199. Rosai J (1991). Borderline epithelial lesions of the breast. Am J Surg Pathol. 15(3):209–21. PMID:1847606

1200. Rosen PP (1989). Adenoid cystic carcinoma of the breast. A morphologically heterogeneous neoplasm. Pathol Annu. 24(Pt 2):237–54. PMID:2549491

1201. Rosen PP (1983). Microglandular adenosis. A benign lesion simulating invasive mammary carcinoma. Am J Surg Pathol. 7(2):137–44. PMID:6859388

1202. Rosen PP (1983). Syringomatous adenoma of the nipple. Am J Surg Pathol. 7(8):739–45. PMID:6660349

1203. Rosen PP (1983). Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. Pathol Annu. 18(Pt 2):215–32. PMID:6674861

1204. Rosen PP (1985). Vascular tumors of the breast. III. Angiomatosis. Am J Surg Pathol. 9(9):652–8. PMID:4051097

1205. Rosen PP (1985). Vascular tumors of the breast. V. Nonparenchymal hemangiomas of mammary subcutaneous tissues. Am J Surg Pathol. 9(10):723–9. PMID:4061730

1206. Rosen PP (1987). Adenomyoepithelioma of the breast. Hum Pathol. 18(12):1232–7. PMID:2824328

1207. Rosen PP (1997). Mammary carcinoma with osteoclast-like giant cells. In: Rosen PP, editor. Rosen’s breast pathology. Philadelphia, New York: Lippincott- Raven; pp. 449–56.

1208. Rosen PP (2001). Myoepithelial neoplasms. In: Rosen PP, editor. Rosen’s breast pathology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; pp. 121–38.

1209. Rosen PP (2008). Angiomas and other benign vascular lesions of the breast. In: Rosen PP, editor. Rosen’s breast pathology. 3rd ed. Philadelphia: Wolters Kluwer, Lippincott Williams & Williams; pp. 872–90.

1210. Rosen PP (2008). Benign mesenchymal neoplasms. In: Rosen PP, editor. Rosen’s breast pathology. 3rd ed. Philadelphia: Wolters Kluwer, Lippincott Williams & Williams; pp. 829–901.

1211. Rosen PP (2008). Myoepithelial neoplasms. In: Rosen’s breast pathology, 3rd edition. Rosen PP, ed. Wolters Kluwer, Lippincott Williams & Williams: Philadelphia: pp. 212

1212. Rosen PP, Caicco JA (1986). Florid papillomatosis of the nipple. A study of 51 patients, including nine with mammary carcinoma. Am J Surg Pathol. 10(2):87–101.http://dx.doi.org/10.1097/00000478-198602000-00002 PMID:3006526.

1213. Rosen PP, Cranor ML (1991). Secretory carcinoma of the breast. Arch Pathol Lab Med. 115(2):141–4. PMID:1992979

1214. Rosen PP, editor (2001). Rosen’s breast pathology. 2nd ed Edition. Lippincott Williams & Wilkins: Philadelphia.

1215. Rosen PP, editor. (2008). Rosen’s Breast Pathology. 3rd ed. Philadelphia: Wolters Kluwer, Lippincott Williams & Williams.

1215A. Rosen PP, Ernsberger D (1987). Low-grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma. Am J Surg Pathol. 11(5):351–8. PMID:3578645

1216. Rosen PP, Ernsberger D (1989). Mammary fibromatosis. A benign spindle-cell tumor with significant risk for local recurrence. Cancer. 63(7):1363–9. PMID:2920364

1217. Rosen PP, Jozefczyk MA, Boram LH (1985). Vascular tumors of the breast. IV. The venous hemangioma. Am J Surg Pathol. 9(9):659–65. PMID:4051098

1218. Rosen PP, Kimmel M, Ernsberger D (1988). Mammary angiosarcoma. The prognostic significance of tumor differentiation. Cancer. 62(10):2145–51. PMID:3179927

1219. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr (1978). Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 2(3):225–51. PMID:210682

1220. Rosen PP, Oberman HA, editors. (1993). Tumors of the mammary gland. Atlas of tumor pathology. Third series, fasc. 7. Washington (D.C.): Armed Forces Institute of Pathology.

1221. Rosen PP, Senie R, Schottenfeld D, Ashikari R (1979). Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 189(3):377–82. PMID:218506

1221A. Rosenblum MK, Purrazzella R, Rosen PP (1986). Is microglandular adenosis a precancerous disease? A study of carcinoma arising therein. Am J Surg Pathol. 10(4):237–45. PMID:3706610

1222. Rosner B, Colditz GA, Willett WC (1994). Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol. 139(8):819–35. PMID:8178795

1223. Ross JS (2009). Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Adv Anat Pathol. 16(4):204–15. PMID:19546609

1224. Rosso R, Scelsi M, Carnevali L (2000). Granular cell traumatic neuroma: a lesion occurring in mastectomy scars. Arch Pathol Lab Med. 124(5):709–11. PMID:10782152

1225. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al.; Writing Group for the Women’s Health Initiative Investigators (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 288(3):321–33. PMID:12117397

1226. Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, Vincent-Salomon A, et al. (2002). Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 20(5):1304–10. PMID:11870173

1227. Rouzier R, Pusztai L, Garbay JR, Delaloge S, Hunt KK, Hortobagyi GN, et al. (2006). Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer. Cancer. 107(7):1459–66. PMID:16948128

1228. Rovera F, Ferrari A, Carcano G, Dionigi G, Cinquepalmi L, Boni L, et al. (2006). Tubular adenoma of the breast in an 84-year-old woman: report of a case simulating breast cancer. Breast J. 12(3):257–9. PMID:16684324

1229. Roylance R, Gorman P, Hanby A, Tomlinson I (2002). Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol. 196(1):32–6. PMID:11748639

1230. Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A, et al. (1999). Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 59(7):1433–6. PMID:10197608

1231. Rozan S, Vincent-Salomon A, Zafrani B, Validire P, De Cremoux P, Bernoux A, et al. (1998). No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer. Int J Cancer. 79(1):27–33. PMID:9495354

1232. Rubin BP, Dal Cin P (2001). The genetics of lipomatous tumors. Semin Diagn Pathol. 18(4):286–93. PMID:11757869

1233. Rubin E, Visscher DW, Alexander RW, Urist MM, Maddox WA (1988). Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer. 61(10):2077–82. PMID:3359405

1234. Rudas M, Neumayer R, Gnant MF, Mittelböck M, Jakesz R, Reiner A (1997). p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur J Cancer. 33(1):39–44. PMID:9071897

1235. Rudloff U, Jacks LM, Goldberg JI, Wynveen CA, Brogi E, Patil S, et al. (2010). Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 28(23):3762–9. PMID:20625132

1236. Rudlowski C, Friedrichs N, Faridi A, Füzesi L, Moll R, Bastert G, et al. (2004). Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat. 84(3):215–23. PMID:15026619

1237. Ruffolo EF, Koerner FC, Maluf HM (1997). Metaplastic carcinoma of the breast with melanocytic differentiation. Mod Pathol. 10(6):592–6. PMID:9195577

1238. Ruijs MW, Broeks A, Menko FH, Ausems MG, Wagner A, Oldenburg R, et al. (2009). The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype. Hered Cancer Clin Pract. 7(1):4. PMID:19338683

1239. Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, et al. (2010). TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet. 47(6):421–8. PMID:20522432

1240. Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, et al. (2010). TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet. 47(6):421–8. PMID:20522432

1241. Ruiz-Delgado ML, López-Ruiz JA, Eizaguirre B, Saiz A, Astigarraga E, Fernández-Temprano Z (2007). Benign adenomyoepithelioma of the breast: imaging findings mimicking malignancy and histopathological features. Acta Radiol. 48(1):27–9. PMID:17325921

1242. Runswick SK, O’Hare MJ, Jones L, Streuli CH, Garrod DR (2001). Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol. 3(9):823–30. PMID:11533662

1242A. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, et al. (2010). Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Transl Med. 2(38):38ra47. PMID:20592421

1243. Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al.; International Extranodal Lymphoma Study Group (2008). Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 19(2):233–41. PMID:17932394

1244. Ryu EM, Whang IY, Chang ED (2010). Rapidly growing bilateral pseudoangiomatous stromal hyperplasia of the breast. Korean J Radiol. 11(3):355–8. PMID:20461190

1245. Saal LH, Gruvberger-Saal SK, Persson C, Lövgren K, Jumppanen M, Staaf J, et al. (2008). Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet. 40(1):102–7. PMID:18066063

1246. Sabaté JM, Gómez A, Torrubia S, Blancas C, Sánchez G, Alonso MC, et al. (2006). Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations. Eur Radiol. 16(3):702–6. PMID:16208511

1247. Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E, et al. (2011). A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat. 126(2):407–20. PMID:20490655

1248. Saglam A, Can B (2005). Coexistence of lactating adenoma and invasive ductal adenocarcinoma of the breast in a pregnant woman. J Clin Pathol. 58(1):87–9. PMID:15623491

1249. Sahlin P, Windh P, Lauritzen C, Emanuelsson M, Grönberg H, Stenman G (2007). Women with Saethre-Chotzen syndrome are at increased risk of breast cancer. Genes Chromosomes Cancer. 46(7):656–60. PMID:17437280

1250. Saigo PE, Rosen PP (1981). Mammary carcinoma with “choriocarcinomatous” features. Am J Surg Pathol. 5(8):773–8. PMID:6278975

1251. Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, et al. (2007). Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline ‘de-novo’ TP53 mutation. Clin Oncol (R Coll Radiol). 19(7):490–3. PMID:17572079

1252. Salto-Tellez M, Putti TC, Lee CK, Chiu LL, Koay ES (2005). Adenomyoepithelioma of the breast: description of allelic imbalance and microsatellite instability. Histopathology. 46(2):230–1. PMID:15693897

1253. Saltzstein SL (1974). Clinically occult inflammatory carcinoma of the breast. Cancer. 34(2):382–8. PMID:4851056

1254. Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD (2006). Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer. 106(7):1453–61. PMID:16502407

1254A. Sanders ME, Schuyler PA, Dupont WD, Page DL (2005). The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 103(12):2481–4. PMID:15884091

1255. Sano M, Kikuchi K, Zhao C, Kobayashi M, Nakanishi Y, Nemoto N (2004). Osteoclastogenesis in human breast carcinoma. Virchows Arch. 444(5):470–2. PMID:15014987

1256. Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS, et al. (2010). Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat. 121(2):431–7. PMID:19774459

1257. Saout L, Leduc M, Suy-Beng PT, Meignie P (1985). [A new case of cribriform breast carcinoma associated with histiocytic giant cell reaction]. Arch Anat Cytol Pathol. 33(1):58–61. PMID:3985689

1258. Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolati G (2000). Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 436(5):421–30. PMID:10881735

1259. Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G (2001). Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol. 14(8):768–76. PMID:11504836

1260. Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G (2000). Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol. 17(2):127–37. PMID:10839613

1261. Sarnaik AA, Meade T, King J, Acs G, Hoover S, Cox CE, et al. (2010). Adenoid cystic carcinoma of the breast: a review of a single institution’s experience. Breast J. 16(2):208–10. PMID:20030648

1262. Sarrió D, Pérez-Mies B, Hardisson D, Moreno-Bueno G, Suárez A, Cano A, et al. (2004). Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene. 23(19):3272–83. PMID:15077190

1263. Sashiyama H, Abe Y, Miyazawa Y, Nagashima T, Hasegawa M, Okuyama K, et al. (1999). Primary non- Hodgkin’s lymphoma of the male breast: a case report. Breast Cancer. 6(1):55–8. PMID:11091691

1264. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, et al. (1996). Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 77(1):113–20. PMID:8630916

1265. Satake N, Durham JH, Brodsky WA (1981). Reversal of the luminal acidification current by a phosphodiesterase inhibitor in the turtle bladder: evidence for active electrogenic biocarbonate secretion. Prog Clin Biol Res. 73:13–24. PMID:6172796

1266. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z (1995). Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg. 180(3):297–306. PMID:7874340

1267. Sau P, Solis J, Lupton GP, James WD (1989). Pigmented breast carcinoma. A clinical and histopathologic simulator of malignant melanoma. Arch Dermatol. 125(4):536–9. PMID:2930211

1268. Sauer T (2010). Fine-needle aspiration cytology of extra mammary metastatic lesions in the breast: A retrospective study of 36 cases diagnosed during 18 years. Cytojournal. 7:10. PMID:20806071

1268A. Saul S (2010). Prone to error: earliest steps to find cancer. New York Times July 19: A1 (http://www.nytimes.com/2010/07/20/ health/20cancer.html?pagewanted=all)

1269. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268(5218):1749–53. PMID:7792600

1270. Sawyer EJ, Hanby AM, Rowan AJ, Gillett CE, Thomas RE, Poulsom R, et al. (2002). The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J Pathol. 196(4):437–44. PMID:11920740

1271. Sawyer EJ, Poulsom R, Hunt FT, Jeffery R, Elia G, Ellis IO, et al. (2003). Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit. J Pathol. 200(1):59–64. PMID:12692842

1272. Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, et al. (2008). The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat. 110(1):189–97. PMID:17687645

1273. Schelfout K, Van Goethem M, Kersschot E, Verslegers I, Biltjes I, Leyman P, et al. (2004). Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol. 14(7):1209–16. PMID:15024602

1274. Schiff R, Osborne CK, Fuqua SAW (2010). Clinical aspects of estrogen and progesterone receptors. In: Harris JR, Lippman ME, Morrow M, Osbourne CK, editors. Diseases of the breast. 4th ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins; pp. 408–30.

1275. Schmidt J, Schelling M, Lerf B, Vogt M (2009). Giant lipoma of the breast. Breast J. 15(1):107–8. PMID:19141137

1276. Schmitt FC, Ribeiro CA, Alvarenga S, Lopes JM (2000). Primary acinic cell-like carcinoma of the breast–a variant with good prognosis? Histopathology. 36(3):286–9. PMID:10809602

1277. Schmitt FC, Soares R, Seruca R (1998). Bilateral apocrine carcinoma of the breast. Molecular and immunocytochemical evidence for two independent primary tumours. Virchows Arch. 433(6):505–9. PMID:9870682

1278. Schmutte C, Marinescu RC, Copeland NG, Jenkins NA, Overhauser J, Fishel R (1998). Refined chromosomal localization of the mismatch repair and hereditary nonpolyposis colorectal cancer genes hMSH2 and hMSH6. Cancer Res. 58(22):5023–6. PMID:9823302

1279. Schnitt SJ (2003). Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol. 27(6):836–41. PMID:12766590

1280. Schnitt SJ (2010). Clinging carcinoma: an American perspective. Semin Diagn Pathol. 27(1):31–6. PMID:20306828

1281. Schnitt SJ, Collins LC (2005). Columnar cell lesions and flat epithelial atypia of the breast. Semin Breast Dis. 8:100–11.

1282. Schnitt SJ, Collins LC (2008). Papillary lesions. In: Biopsy interpretation of the breast.Schnitt SJ, Collins LC, eds. Biopsy interpretation series. Wolters Kluwer/Lippincott Williams & Wilkins: Philadelphia: pp 205–235.

1283. Schnitt SJ, Connolly JL, Harris JR, Cohen RB (1984). Radiation-induced changes in the breast. Hum Pathol. 15(6):545–50. PMID:6724573

1284. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, et al. (1992). Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol. 16(12):1133–43. PMID:1463092

1285. Schnitt SJ, Vincent-Salomon A (2003). Columnar cell lesions of the breast. Adv Anat Pathol. 10(3):113–24. PMID:12717115

1285A. Schrader KA, Nelson TN, De Luca A, Huntsman DG, McGillivray BC (2009). Multiple granular cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11. Clin Genet. 75(2):185–9. PMID:19054014

1286. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M (1998). Clinical and pathological features of breast disease in Cowden’s syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol. 29(1):47–53. PMID:9445133

1287. Schramm N, Pfluger T, Reiser MF, Berger F (2010). Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings. Br J Radiol. 83(989):e90–4. PMID:20418462

1288. Schwartz GF, Patchefsky AS, Finklestein SD, Sohn SH, Prestipino A, Feig SA, et al. (1989). Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment. Arch Surg. 124(1):29–32. PMID:2535928

1289. Schwentner L, Kurzeder C, Kreienberg R, Wöckel A (2011). Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institutional experience. Arch Gynecol Obstet. 283(3):591–6. PMID:21069366

1290. Scopsi L, Andreola S, Pilotti S, Bufalino R, Baldini MT, Testori A, et al. (1994). Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol. 18(7):702–11. PMID:8017565

1291. Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, et al. (2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet. 68(1):118–27. PMID:11112663

1292. Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC (2010). Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 101(5):401–7. PMID:20119983

1293. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, et al.; Breast Cancer Susceptibility Collaboration (UK) (2006). Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet. 38(11):1239–41. PMID:17033622

1294. Sek P, Zawrocki A, Biernat W, Piekarski JH (2010). HER2 molecular subtype is a dominant subtype of mammary Paget’s cells. An immunohistochemical study. Histopathology. 57(4):564–71. PMID:20955381

1295. Selinko VL, Middleton LP, Dempsey PJ (2004). Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 32(7):323–32. PMID:15293298

1296. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, et al. (2008). The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 135(2):419–28. PMID:18602922

1297. Sgroi DC (2010). Preinvasive breast cancer. Annu Rev Pathol. 5:193–221. PMID:19824828

1297A. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, et al. (2009). Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 461(7265):809–13. PMID:19812674

1298. Shanley S, Fung C, Milliken J, Leary J, Barnetson R, Schnitzler M, et al. (2009). Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Fam Cancer. 8(3):251–5. PMID:19123071

1299. Shehata BM, Fishman I, Collings MH, Wang J, Poulik JM, Ricketts RR, et al. (2009). Pseudoangiomatous stromal hyperplasia of the breast in pediatric patients: an underrecognized entity. Pediatr Dev Pathol. 12(6):450–4. PMID:19606909

1300. Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, et al. (2007). Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 128(1):157–70. PMID:17218262

1301. Shepherd JJ, Wright DH (1967). Burkitt’s tumour presenting as bilateral swelling of the breast in women of child-bearing age. Br J Surg. 54(9):776–80. PMID:6047810

1302. Sheppard DG, Whitman GJ, Huynh PT, Sahin AA, Fornage BD, Stelling CB (2000). Tubular carcinoma of the breast: mammographic and sonographic features. AJR Am J Roentgenol. 174(1):253–7. PMID:10628489

1303. Sheth NA, Saruiya JN, Ranadive KJ, Sheth AR (1974). Ectopic production of human chorionic gonadotrophin by human breast tumours. Br J Cancer. 30(6):566–70. PMID:4374964

1304. Shibata A, Tsai YC, Press MF, Henderson BE, Jones PA, Ross RK (1996). Clonal analysis of bilateral breast cancer. Clin Cancer Res. 2(4):743–8. PMID:9816225

1305. Shien T, Tashiro T, Omatsu M, Masuda T, Furuta K, Sato N, et al. (2005). Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation. J Clin Pathol. 58(12):1299–304. PMID:16311351

1306. Shiloh Y (2003). ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 3(3):155–68. PMID:12612651

1307. Shin HJ, Kim HH, Kim SM, Kim DB, Lee YR, Kim MJ, et al. (2007). Pure and mixed tubular carcinoma of the breast: mammographic and sonographic differential features. Korean J Radiol. 8(2):103–10. PMID:17420627

1308. Shin SJ, DeLellis RA, Ying L, Rosen PP (2000). Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 24(9):1231–8. PMID:10976697

1309. Shin SJ, Kanomata N, Rosen PP (2000). Mammary carcinoma with prominent cytoplasmic lipofuscin granules mimicking melanocytic differentiation. Histopathology. 37(5):456–9. PMID:11119128

1310. Shin SJ, Rosen PP (2002). Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases. Am J Surg Pathol. 26(4):413–20. PMID:11914618

1311. Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, et al. (2009). Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Am J Surg Pathol. 33(4):496–504. PMID:19047897

1312. Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, Kasumi F, et al. (2002). Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res. 62(2):560–6. PMID:11809710

1313. Shirley SE, Duncan ND, Escoffery CT, West AB (2002). Angiomatosis of the breast in a male child. A case report with immunohistochemical analysis. West Indian Med J. 51(4):254–6. PMID:12632645

1314. Shishido-Hara Y, Kurata A, Fujiwara M, Itoh H, Imoto S, Kamma H (2010). Two cases of breast carcinoma with osteoclastic giant cells: are the osteoclastic giant cells pro-tumoural differentiation of macrophages? Diagn Pathol. 5:55. PMID:20731838

1315. Shousha S (2007). Glandular Paget’s disease of the nipple. Histopathology. 50(6):812–4. PMID:17376174

1316. Shousha S, Backhous CM, Alaghband-Zadeh J, Burn I (1986). Alveolar variant of invasive lobular carcinoma of the breast. A tumor rich in estrogen receptors. Am J Clin Pathol. 85(1):1–5. PMID:3940412

1317. Shousha S, Schoenfeld A, Moss J, Shore I, Sinnett HD (1994). Light and electron microscopic study of an invasive cribriform carcinoma with extensive microcalcification developing in a breast with silicone augmentation. Ultrastruct Pathol. 18(5):519–23. PMID:7810003

1318. Shousha S, Tisdall M, Sinnett HD (2004). Paget’s disease of the nipple occurring after conservative surgery for ductal carcinoma in situ of the breast. Histopathology. 45(4):416–8. PMID:15469484

1319. Sidwell RU, Rouse P, Owen RA, Green JS (2008). Granular cell tumor of the scrotum in a child with Noonan syndrome. Pediatr Dermatol. 25(3):341–3. PMID:18577039

1320. Silver SA, Tavassoli FA (1998). Primary osteogenic sarcoma of the breast: a clinicopathologic analysis of 50 cases. Am J Surg Pathol. 22(8):925–33. PMID:9706972

1321. Silver SA, Tavassoli FA (2000). Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma. Histopathology. 36(6):505–14. PMID:10849092

1322. Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, et al. (2009). Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol. 11(7):903–8. PMID:19525934

1323. Silverman EM, Oberman HA (1974). Metastatic neoplasms in the breast. Surg Gynecol Obstet. 138(1):26–8. PMID:4809000

1324. Silverstein MJ, Lagios MD (2010). Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index. J Natl Cancer Inst Monogr. 2010(41):193–6. PMID:20956828

1325. Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R, et al. (2005). Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 201(4):586–97. PMID:16183499

1326. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, et al. (1994). Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 73(6):1673–7. PMID:8156495

1326A. Simpson JF, Sanders ME, Page DL (2011). Diagnostic accuracy of ductal carcinoma in situ: results of Eastern Cooperative Oncology Trial 5194. Lab Invest. 91:64A.

1327. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, et al. (2005). Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 29(6):734–46. PMID:15897740

1328. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Steele D, et al. (2004). Distribution and significance of 14–3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue. J Pathol. 202(3):274–85. PMID:14991892

1329. Simpson PT, Reis-Filho JS, Lambros MB, Jones C, Steele D, Mackay A, et al. (2008). Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol. 215(3):231–44. PMID:18473330

1330. Simpson RH, Cope N, Skálová A, Michal M (1998). Malignant adenomyoepithelioma of the breast with mixed osteogenic, spindle cell, and carcinomatous differentiation. Am J Surg Pathol. 22(5):631–6. PMID:9591734

1331. Singh KA, Lewis MM, Runge RL, Carlson GW (2007). Pseudoangiomatous stromal hyperplasia. A case for bilateral mastectomy in a 12-year-old girl. Breast J. 13(6):603–6. PMID:17983404

1332. Sinha PS, Bendall S, Bates T (2000). Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers? Eur J Surg Oncol. 26(8):733–7. PMID:11087636

1333. Sinilnikova OM, Egan KM, Quinn JL, Boutrand L, Lenoir GM, Stoppa-Lyonnet D, et al. (1999). Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer. 82(3):325–8. PMID:10399947

1334. Siponen E, Hukkinen K, Heikkilä P, Joensuu H, Leidenius M (2010). Surgical treatment in Paget’s disease of the breast. Am J Surg. 200(2):241–6. PMID:20678619

1335. Siriaunkgul S, Tavassoli FA (1993). Invasive micropapillary carcinoma of the breast. Mod Pathol. 6(6):660–2. PMID:8302807

1336. Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. (2010). Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 34(5):599–608. PMID:20410810

1337. Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B (2008). Incidence and management of complex fibroadenomas. AJR Am J Roentgenol. 190(1):214–8. PMID:18094314

1338. Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, et al.; European Commission Working Group on Breast Screening Pathology (1998). Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. Hum Pathol. 29(10):1056–62. PMID:9781641

1339. Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, et al.; European Commission Working Group on Breast Screening Pathology (1999). Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. Virchows Arch. 434(1):3–10. PMID:10071228

1340. Sloane JP, Mayers MM (1993). Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology. 23(3):225–31. PMID:8225240

1341. Smith BH, Taylor HB (1969). The occurrence of bone and cartilage in mammary tumors. Am J Clin Pathol. 51(5):610–8. PMID:4305299

1342. Smith DN, Denison CM, Lester SC (1996). Spindle cell lipoma of the breast. A case report. Acta Radiol. 37(6):893–5. PMID:8995461

1343. Smith PA, Harlow SP, Krag DN, Weaver DL (1999). Submission of lymph node tissue for ancillary studies decreases the accuracy of conventional breast cancer axillary node staging. Mod Pathol. 12(8):781–5. PMID:10463480

1344. Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, et al. (1996). Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res. 6(11):1029–49. PMID:8938427

1345. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, et al. (1998). Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 279(7):535–40. PMID:9480365

1346. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP (2002). Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 15(10):1044–50. PMID:12379750

1347. Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, et al. (2001). Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol. 25(8):1009–16. PMID:11474284

1348. Sneige N, Zachariah S, Fanning TV, Dekmezian RH, Ordóñez NG (1989). Fine-needle aspiration cytology of metastatic neoplasms in the breast. Am J Clin Pathol. 92(1):27–35. PMID:2750705

1349. Soliman AS, Banerjee M, Lo AC, Ismail K, Hablas A, Seifeldin IA, et al. (2009). High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt. Breast J. 15(4):432–4. PMID:19601951

1349A. Solin LJ, Baehner FL, Butler S, Badve S, Yoshizawa C, Shak S, et al. (2011). A quantitative multigene RT-PCR assay for predicting recurrence risk after surgical excision alone without irradiation for ductal carcinoma in situ (DCIS): A prospective validation study of the DCIS Score from ECOG E5194. Cancer Res. 71:108S.

1350. Somerville JE, Clarke LA, Biggart JD (1992). c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. J Clin Pathol. 45(1):16–20. PMID:1346789

1351. Somlo G, Frankel P, Chow W, Leong L, Margolin K, Morgan R Jr, et al. (2004). Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy. J Clin Oncol. 22(10):1839–48. PMID:15143076

1352. Soo MS, Dash N, Bentley R, Lee LH, Nathan G (2000). Tubular adenomas of the breast: imaging findings with histologic correlation. AJR Am J Roentgenol. 174(3):757–61. PMID:10701621

1353. Soo MS, Rosen EL, Baker JA, Vo TT, Boyd BA (2001). Negative predictive value of sonography with mammography in patients with palpable breast lesions. AJR Am J Roentgenol. 177(5):1167–70. PMID:11641195

1354. Soomro S, Shousha S, Taylor P, Shepard HM, Feldmann M (1991). c-erbB-2 expression in different histological types of invasive breast carcinoma. J Clin Pathol. 44(3):211–4. PMID:1672872

1355. Søreide JA, Anda O, Eriksen L, Holter J, Kjellevold KH (1988). Pleomorphic adenoma of the human breast with local recurrence. Cancer. 61(5):997–1001. PMID:2827885

1355A. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, et al. (2010). The importance of gene-centring microarray data. Lancet Oncol. 11(8):719–20, author reply 720–1. PMID:20688275

1356. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 98(19):10869–74. PMID:11553815

1357. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 100(14):8418–23. PMID:12829800

1357A. Sotelo-Avila C, Bale PM (1994). Subdermal fibrous hamartoma of infancy: pathology of 40 cases and differential diagnosis. Pediatr Pathol. 14(1):39–52. PMID:8159619

1358. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. (2006). Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 98(4):262–72. PMID:16478745

1359. Sparano JA, Paik S (2008). Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol. 26(5):721–8. PMID:18258979

1360. Squillaci S, Tallarigo F, Patarino R, Bisceglia M (2007). Nodular fasciitis of the male breast: a case report. Int J Surg Pathol. 15(1):69–72. PMID:17172503

1361. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH (1990). Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 348(6303):747–9. PMID:2259385

1361A. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 39(7):865–9. PMID:17529974

1361B. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. (2008). Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 40(6):703–6. PMID:18438407

1362. Staff S, Nupponen NN, Borg A, Isola JJ, Tanner MM (2000). Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers. Genes Chromosomes Cancer. 28(4):432–42. PMID:10862052

1363. Staklenac B, Pauzar B, Pajtler M, Loncar B, Dmitrović B (2004). An unusual tumour of the breast: cytological findings. Cytopathology. 15(3):160–2. PMID:15165273

1363A. Stalsberg H, Thomas DB (1993). Age distribution of histologic types of breast carcinoma. Int J Cancer. 54(1):1–7. PMID:8478135

1364. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, et al. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95(1):29–39. PMID:9778245

1365. Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, et al. (1998). ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 62(2):334–45. PMID:9463314

1366. Stanley MW, Skoog L, Tani EM, Horwitz CA (1993). Nodular fasciitis: spontaneous resolution following diagnosis by fine-needle aspiration. Diagn Cytopathol. 9(3):322–4. PMID:8519200

1367. Starink TM, van der Veen JP, Arwert F, de Waal LP, de Lange GG, Gille JJ, et al. (1986). The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet. 29(3):222–33. PMID:3698331

1368. Stark M, Hoffmann A, Xiong Z (2011). Mammary myofibrosarcoma: case report and literature review. Breast J. 17(3):300–4. PMID:21545434

1369. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA (1995). Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 196(1):123–34. PMID:7784555

1370. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 15(4):356–62. PMID:9090379

1371. Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, et al.; WHI Investigators (2006). Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 295(14):1647–57. PMID:16609086

1372. Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, Valgeirsdottir S, et al. (2009). Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes. Breast Cancer Res. 11(4):R47. PMID:19589159

1373. Steffen J, Nowakowska D, Niwińska A, Czapczak D, Kluska A, Piatkowska M, et al. (2006). Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer. 119(2):472–5. PMID:16770759

1374. Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, et al. (2008). An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res. 68(15):6084–91. PMID:18676830

1375A. Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, et al. (2005). A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet. 37(6):590–2. PMID:15908952

1375. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, et al. (2009). Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 462(7276):1005–10. PMID:20033038

1376. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH (1997). The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res. 3(11):1949–58. PMID:9815584

1377. Stout AP, Murray MR (1942). Hemangiopericytoma: a vascular tumor featuring Zimmermann’s pericytes. Ann Surg. 116(1):26–33. PMID:17858068

1378. Stovall M, Smith SA, Langholz BM, Boice JD Jr, Shore RE, Andersson M, et al.; Women’s Environmental, Cancer, and Radiation Epidemiology Study Collaborative Group (2008). Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 72(4):1021–30. PMID:18556141

1379. Stutz JA, Evans AJ, Pinder S, Ellis IO, Yeoman LJ, Wilson AR, et al.; Nottingham Breast Team (1994). The radiological appearances of invasive cribriform carcinoma of the breast. Clin Radiol. 49(10):693–5. PMID:7955831

1380. Su X, Hankinson SE, Clevenger CV, Eliassen AH, Tworoger SS (2009). Energy balance, early life body size, and plasma prolactin levels in postmenopausal women. Cancer Causes Control. 20(2):253–62. PMID:18853263

1381. Su Y, Swift M (2001). Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations. JAMA. 286(18):2233–4. PMID:11710885

1382. Sullivan ME, Khan SA, Sullu Y, Schiller C, Susnik B (2010). Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med. 134(7):1024–8. PMID:20586632

1383. Sullivan T, Raad RA, Goldberg S, Assaad SI, Gadd M, Smith BL, et al. (2005). Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat. 93(3):199–205. PMID:16142444

1384. Sumpio BE, Jennings TA, Merino MJ, Sullivan PD (1987). Adenoid cystic carcinoma of the breast. Data from the Connecticut Tumor Registry and a review of the literature. Ann Surg. 205(3):295–301. PMID:3030200

1385. Suster S, Wong TY (1994). Polymorphous sweat gland carcinoma. Histopathology. 25(1):31–9. PMID:7959643

1386. Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008). Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status–a meta-analysis of epidemiological studies. Int J Cancer. 122(8):1832–41. PMID:18067133

1387. Suzuki T, Miki Y, Takagi K, Hirakawa H, Moriya T, Ohuchi N, et al. (2010). Androgens in human breast carcinoma. Med Mol Morphol. 43(2):75–81. PMID:20683693

1388. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al., editors. (2008). WHO classification of tumours of haematopoietic and lymphoid tissues. WHO classification of tumours. 4th ed. Lyon: IARC.

1389. Swift M, Morrell D, Massey RB, Chase CL (1991). Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 325(26):1831–6. PMID:1961222

1390. Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, et al. (2007). Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 25(28):4414–22. PMID:17785706

1391. Taccagni G, Rovere E, Masullo M, Christensen L, Eyden B (1997). Myofibrosarcoma of the breast: review of the literature on myofibroblastic tumors and criteria for defining myofibroblastic differentiation. Am J Surg Pathol. 21(4):489–96. PMID:9130998

1392. Tai YC, Domchek S, Parmigiani G, Chen S (2007). Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 99(23):1811–4. PMID:18042939

1393. Tait R, Pinder SE, Ellis IO, Purushotham AD (2005). Adenomyoepithelioma of the breast; a case report and literature review. J BUON. 10(3):393–5. PMID:17357195

1394. Talley C, Kushner HI, Sterk CE (2004). Lung cancer, chronic disease epidemiology, and medicine, 1948–1964. J Hist Med Allied Sci. 59(3):329–74. PMID:15270334

1395. Talman ML, Jensen MB, Rank F (2007). Invasive lobular breast cancer. Prognostic significance of histological malignancy grading. Acta Oncol. 46(6):803–9. PMID:17653904

1396. Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ (2008). Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 32(9):1299–309. PMID:18636016

1397. Talwar S, Prasad N, Gandhi S, Prasad P (1999). Haemangiopericytoma of the adult male breast. Int J Clin Pract. 53(6):485–6. PMID:10622081

1398. Tamura G, Monma N, Suzuki Y, Satodate R, Abe H (1993). Adenomyoepithelioma (myoepithelioma) of the breast in a male. Hum Pathol. 24(6):678–81. PMID:8389319

1399. Tamura S, Enjoji M, Toyoshima S, Terasaka R (1988). Adenomyoepithelioma of the breast. A case report with an immunohistochemical study. Acta Pathol Jpn. 38(5):659–65. PMID:2850707

1400. Tan EY, Tan PH, Yong WS, Wong HB, Ho GH, Yeo AW, et al. (2006). Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg. 76(6):476–80. PMID:16768772

1401. Tan H, Zhang S, Liu H, Peng W, Li R, Gu Y, et al. (2011). Imaging findings in phyllodes tumors of the breast. Eur J Radiol. PMID:21353414

1402. Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, et al. (2011). A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet. 88(1):42–56. PMID:21194675

1403. Tan PH, Aw MY, Yip G, Bay BH, Sii LH, Murugaya S, et al. (2005). Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol. 29(5):625–32. PMID:15832086

1403A. Tan PH, Lui GG, Chiang G, Yap WM, Poh WT, Bay BH (2004). Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions. Histopathology. 45(4):343–51. PMID:15469472

1404. Tan PH, Jayabaskar T, Chuah KL, Lee HY, Tan Y, Hilmy M, et al. (2005). Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol. 123(4):529–40. PMID:15743740

1405. Tan PH, Jayabaskar T, Yip G, Tan Y, Hilmy M, Selvarajan S, et al. (2005). p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol. 18(12):1527–34. PMID:16258510

1406. Tan PH, Thike AA, Tan WJ, Thu MM, Busmanis I, Li H, et al.; Phyllodes Tumour Network Singapore (2012). Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 65(1):69–76. PMID:22049216

1407. Tan PH, Tse GM, Bay BH (2008). Mucinous breast lesions: diagnostic challenges. J Clin Pathol. 61(1):11–9. PMID:17873114

1408. Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, et al. (2011). Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology. 59(1):106–15. PMID:21668471

1409. Tang G, Shak S, Paik S, Anderson SJ, Costantino JP, Geyer CE Jr, et al. (2011). Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20. Breast Cancer Res Treat. 127(1):133–42. PMID:21221771

1410. Tavassoli FA (1991). Myoepithelial lesions of the breast. Myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am J Surg Pathol. 15(6):554–68. PMID:1709559

1411. Tavassoli FA (1999). Myoepithelial lesions. In: Tavassoli FA, editor. Pathology of the breast. 2nd ed. New York: Appleton & Lange; pp. 763–91.

1412. Tavassoli FA, Bratthauer GL (1993). Immunohistochemical profile and differential diagnosis of microglandular adenosis. Mod Pathol. 6(3):318–22. PMID:8346180

1413. Tavassoli FA, Devilee P, editors. (2003). WHO classification of tumours of the breast and female genital organs. 3rd ed. Lyon, France: IARC.

1414. Tavassoli FA, editor. (1999). Pathology of the breast. 2nd ed. Stamford (Connecticut): Appleton & Lange.

1415. Tavassoli FA, Eusebi V (2009). Benign soft tissue lesions. In: Tumors of the mammary gland.Tavassoli FA, Eusebi V, eds. AFIP atlas of tumor pathology. Fourth series; fasc. 10. American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology: Washington, D.C: pp 263–285.

1416. Tavassoli FA, Eusebi V, editors (2009). Tumors of the mammary gland. AFIP atlas of tumor pathology. Fourth series; fasc. 10. American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology: Washington, D.C.

1417. Tavassoli FA, Norris HJ (1980). Secretory carcinoma of the breast. Cancer. 45(9):2404–13. PMID:6445777

1418. Tavassoli FA, Norris HJ (1986). Mammary adenoid cystic carcinoma with sebaceous differentiation. A morphologic study of the cell types. Arch Pathol Lab Med. 110(11):1045–53. PMID:3022669

1419. Tavassoli FA, Norris HJ (1990). A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 65(3):518–29. PMID:2297643

1420. Tavassoli FA, Weiss S (1981). Hemangiopericytoma of the breast. Am J Surg Pathol. 5(8):745–52. PMID:6278973

1421. Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, et al.; Australian Cancer Study; Breast Cancer Family Registries (BCFR); Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab) (2009). Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet. 85(4):427–46. PMID:19781682

1422. Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, et al.; Australian Cancer Study; Breast Cancer Family Registries (BCFR); Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab) (2009). Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet. 85(4):427–46. PMID:19781682

1423. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, et al. (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 12(3):333–7. PMID:8589730

1424. Taylor HB, Robertson AG (1965). Adenomas of the nipple. Cancer. 18:995–1002. PMID:14326498

1425. Telesinghe PU, Anthony PP (1985). Primary lymphoma of the breast. Histopathology. 9(3):297–307. PMID:3922871

1426. Teresi RE, Zbuk KM, Pezzolesi MG, Waite KA, Eng C (2007). Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation. Am J Hum Genet. 81(4):756–67. PMID:17847000

1427. Terrier P, Terrier-Lacombe MJ, Mouriesse H, Friedman S, Spielmann M, Contesso G (1989). Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat. 13(1):39–48. PMID:2468372

1428. Tesluk H, Amott T, Goodnight JE Jr (1986). Apocrine adenoma of the breast. Arch Pathol Lab Med. 110(4):351–2. PMID:3754126

1429. Thanapaisal C, Koonmee S, Siritunyaporn S (2006). Malignant peripheral nerve sheath tumor of breast in patient without Von Recklinghausen’s neurofibromatosis: a case report. J Med Assoc Thai. 89(3):377–9. PMID:16696423

1430. Breast Cancer Linkage Consortium (1999). Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 91(15):1310–6. PMID:10433620

1431. The Consensus Conference Committee (1997). Consensus Conference on the classification of ductal carcinoma in situ. Cancer. 80(9):1798–802. PMID:9351550

1431A. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. (2009). A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 41(5):579–84. PMID:19330030

1432. Thomas JS, Julian HS, Green RV, Cameron DA, Dixon MJ (2007). Histopathology of breast carcinoma following neoadjuvant systemic therapy: a common association between letrozole therapy and central scarring. Histopathology. 51(2):219–26. PMID:17650216

1433. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, et al. (2005). Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst. 97(11):813–22. PMID:15928302

1434. Thompson D, Easton D; Breast Cancer Linkage Consortium (2001). Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet. 68(2):410–9. PMID:11170890

1435. Thompson D, Easton D; Breast Cancer Linkage Consortium (2002). Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev. 11(4):329–36. PMID:11927492

1436. Thompson D, Easton DF; Breast Cancer Linkage Consortium (2002). Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 94(18):1358–65. PMID:12237281

1436A. Thompson L, Chang B, Barsky SH (1996). Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 20(3):277–85. PMID:8772780

1437. Thompson PA, Lade S, Webster H, Ryan G, Prince HM (2010). Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 95(11):1977–9. PMID:20801901

1438. Thor AD, Eng C, Devries S, Paterakos M, Watkin WG, Edgerton S, et al. (2002). Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum Pathol. 33(6):628–31. PMID:12152162

1439. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, et al. (1998). Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet. 352(9137):1337–9. PMID:9802270

1440. Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, et al. (2009). 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol. 27(26):e108–9, author reply e110. PMID:19652052

1441. Tischkowitz M, Xia B (2010). PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res. 70(19):7353–9. PMID:20858716

1442. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, et al. (2002). Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2(5):367–76. PMID:12450792

1443. Toikkanen S, Kujari H (1989). Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up. Hum Pathol. 20(8):758–64. PMID:2545592

1444. Toikkanen S, Pylkkänen L, Joensuu H (1997). Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer. 76(9):1234–40. PMID:9365176

1445. Toker C (1961). Some observations on Paget’s disease of the nipple. Cancer. 14:653–72. PMID:13777220

1446. Toker C (1970). Clear cells of the nipple epidermis. Cancer. 25(3):601–10. PMID:4313654

1447. Tommiska J, Bartkova J, Heinonen M, Hautala L, Kilpivaara O, Eerola H, et al. (2008). The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene. 27(17):2501–6. PMID:17982490

1448. Toombs BD, Kalisher L (1977). Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol. 129(4):673–6. PMID:409241

1449. Topalovski M, Crisan D, Mattson JC (1999). Lymphoma of the breast. A clinicopathologic study of primary and secondary cases. Arch Pathol Lab Med. 123(12):1208–18. PMID:10583925

1450. Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, et al. (2005). Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol. 29(11):1482–9. PMID:16224215

1451. Tot T (2007). Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections. Cancer. 110(11):2551–60. PMID:17932896

1452. Tóth J (1977). Benign human mammary myoepithelioma. Virchows Arch A Pathol Anat Histol. 374(3):263–9. PMID:196390

1452A. Toussaint J, Sieuwerts AM, Haibe-Kains B, Desmedt C, Rouas G, Harris AL, et al. (2009). Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues. BMC Genomics. 10:424. PMID:19744330

1453. Tresserra F, Grases PJ, Fábregas R, Férnandez-Cid A, Dexeus S (1999). Invasive micropapillary carcinoma. Distinct features of a poorly recognized variant of breast carcinoma. Eur J Gynaecol Oncol. 20(3):205–8. PMID:10410887

1454. Trojani M, De Mascarel I, Coquet M, Coindre JM, De Mascarel A (1989). [Osteoclastic type giant cell carcinoma of the breast]. Ann Pathol. 9(3):189–94. PMID:2757703

1455. Trojani M, Guiu M, Trouette H, De Mascarel I, Cocquet M (1992). Malignant adenomyoepithelioma of the breast. An immunohistochemical, cytophotometric, and ultrastructural study of a case with lung metastases. Am J Clin Pathol. 98(6):598–602. PMID:1334365

1456. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, et al. (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 128(1):141–56. PMID:17218261

1457. Troxell ML, Levine J, Beadling C, Warrick A, Dunlap J, Presnell A, et al. (2010). High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod Pathol. 23(1):27–37. PMID:19898424

1458. Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, et al. (2005). Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology. 128(5):1160–71. PMID:15887099

1459. Tsang WY, Chan JK (1996). Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol. 20(8):921–43. PMID:8712293

1460. Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC, et al. (2002). Hamartoma of the breast: a clinicopathological review. J Clin Pathol. 55(12):951–4. PMID:12461066

1461. Tse GM, Lui PC, Lee CS, Kung FY, Scolyer RA, Law BK, et al. (2004). Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Hum Pathol. 35(9):1053–7. PMID:15343505

1462. Tse GM, Lui PC, Scolyer RA, Putti TC, Kung FY, Law BK, et al. (2003). Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors. Mod Pathol. 16(10):1007–13. PMID:14559983

1462A. Tse GM, Lui PC, Vong JS, Lau KM, Putti TC, Karim R, et al. (2009). Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Res Treat. 114(3):441–8. PMID:18443904

1463. Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, et al. (2007). The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast. J Clin Pathol. 60(3):315–20. PMID:16698948

1464. Tse GM, Tan PH, Moriya T (2009). The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast. J Clin Pathol. 62(5):407–13. PMID:19126567

1464A. Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK (2006). Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol. 59(10):1079–83. PMID:16467167

1465. Tsubura A, Hatano T, Murata A, Shoji T, Shikata N, Morii S (1992). Breast carcinoma in patients receiving neuroleptic therapy. Morphologic and clinicopathologic features of thirteen cases. Acta Pathol Jpn. 42(7):494–9. PMID:1357916

1466. Tsuda H, Fukutomi T, Hirohashi S (1995). Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Clin Cancer Res. 1(3):261–7. PMID:9815981

1466A. Tsuda H, Takarabe T, Fukutomi T, Hirohashi S (1999). der(16)t(1;16)/der(1;16) in breast cancer detected by fluorescence in situ hybridization is an indicator of better patient prognosis. Genes Chromosomes Cancer. 24(1):72–7. PMID:9892111

1467. Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, et al. (2010). Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. Breast Cancer Res. 12(6):R95. PMID:21080930

1468. Tung N, Wang Y, Collins LC, Kaplan J, Li H, Gelman R, et al. (2010). Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res. 12(1):R12. PMID:20149218

1469. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 7:55. PMID:17389037

1469A. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al.; Breast Cancer Susceptibility Collaboration (UK) (2010). Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 42(6):504–7. PMID:20453838

1470. Turner N, Tutt A, Ashworth A (2004). Hallmarks of ‘BRCAness’ in sporadic cancers. Nat Rev Cancer. 4(10):814–9. PMID:15510162

1471. Turner NC, Reis-Filho JS (2006). Basal-like breast cancer and the BRCA1 phenotype. Oncogene. 25(43):5846–53. PMID:16998499

1472. Turpin E, Bièche I, Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, et al. (2002). Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer. Oncogene. 21(49):7593–7. PMID:12386822

1473. Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, et al. (2010). Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. 376(9737):235–44. PMID:20609467

1474. Tworoger SS, Hankinson SE (2008). Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia. 13(1):41–53. PMID:18246319

1475. Uchin JM, Billings SD (2009). Radiotherapy-associated atypical vascular lesions of the breast. J Cutan Pathol. 36(1):87–8. PMID:19125741

1476. Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, et al.; SEARCH Collaborators (2009). FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet. 18(9):1692–703. PMID:19223389

1477. Ueng SH, Mezzetti T, Tavassoli FA (2009). Papillary neoplasms of the breast: a review. Arch Pathol Lab Med. 133(6):893–907. PMID:19492881

1478. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, et al. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 96(4):261–8. PMID:14970275

1479. Ursin G, Longnecker MP, Haile RW, Greenland S (1995). A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 6(2):137–41. PMID:7742399

1480. Uziel T, Savitsky K, Platzer M, Ziv Y, Helbitz T, Nehls M, et al. (1996). Genomic Organization of the ATM gene. Genomics. 33(2):317–20. PMID:8660985

1481. Vahteristo P, Bartkova J, Eerola H, Syrjäkoski K, Ojala S, Kilpivaara O, et al. (2002). A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet. 71(2):432–8. PMID:12094328

1482. Validire P, Capovilla M, Asselain B, Kirova Y, Goudefroye R, Plancher C, et al. (2009). Primary breast non-Hodgkin’s lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Am J Hematol. 84(3):133–9. PMID:19199367

1483. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, et al.; Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON) (2005). Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet. 42(9):711–9. PMID:16141007

1484. van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P, et al. (2005). Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res. 65(3):822–7. PMID:15705879

1485. van Bogaert LJ, Maldague P (1977). Histologic variants of lipid-secreting carcinoma of the breast. Virchows Arch A Pathol Anat Histol. 375(4):345–53. PMID:199989

1486. van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 347(25):1999–2009. PMID:12490681

1487. Van den Eynden GG, Van der Auwera I, Van Laere S, Colpaert CG, van Dam P, Merajver S, et al. (2004). Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Res Treat. 85(1):13–22. PMID:15039594

1488. Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, et al. (2005). Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res. 11(21):7637–42. PMID:16278382

1489. Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, et al. (2004). Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res. 10(23):7965–71. PMID:15585631

1490. van Deurzen CH, Cserni G, Bianchi S, Vezzosi V, Arisio R, Wesseling J, et al. (2010). Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classification. J Clin Oncol. 28(6):999–1004. PMID:20085942

1491. Van Dorpe J, De Pauw A, Moerman P (1998). Adenoid cystic carcinoma arising in an adenomyoepithelioma of the breast. Virchows Arch. 432(2):119–22. PMID:9504855

1492. van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD (2002). Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis. 19(4):301–11. PMID:12090470

1493. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD (2000). RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res. 60(20):5832–8. PMID:11059780

1493A. Van Hoeven KH, Drudis T, Cranor ML, Erlandson RA, Rosen PP (1993). Low-grade adenosquamous carcinoma of the breast. A clinocopathologic study of 32 cases with ultrastructural analysis. Am J Surg Pathol. 17(3):248–58. PMID:8434705

1494. Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, et al. (2005). Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Res Treat. 93(3):237–46. PMID:16172796

1495. van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME (2010). High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol. 105(6):1258–64, author reply 1265. PMID:20051941

1495A. van Wezel T, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, et al. (2005). Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Breast Cancer Res. 7(6):R998–1004. PMID:16280054

1496. van ‘t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415(6871):530–6. PMID:11823860

1497. Varga Z, Kolb SA, Flury R, Burkhard R, Caduff R (2000). Sebaceous carcinoma of the breast. Pathol Int. 50(1):63–6. PMID:10692180

1498. Varga Z, Robl C, Spycher M, Burger D, Caduff R (1998). Metaplastic lipid-rich carcinoma of the breast. Pathol Int. 48(11):912–6. PMID:9832063

1499. Varga Z, Zhao J, Ohlschlegel C, Odermatt B, Heitz PU (2004). Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer. Histopathology. 44(4):332–8. PMID:15049898

1500. Vargas AC, Da Silva L, Lakhani SR (2010). The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers. Fam Cancer. 9(4):545–53. PMID:20577821

1501. Varghese JS, Easton DF (2010). Genome-wide association studies in common cancers–what have we learnt? Curr Opin Genet Dev. 20(3):201–9. PMID:20418093

1502. Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, et al. (1999). Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. Am J Hum Genet. 65(4):995–1006. PMID:10486318

1503. Vasen HF (2005). Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer. 4(3):219–25. PMID:16136381

1504. Vasen HF, Morreau H, Nortier JW (2001). Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet. 68(6):1533–5. PMID:11359214

1505. Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, et al. (2001). MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol. 19(20):4074–80. PMID:11600610

1506. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 116(6):1453–6. PMID:10348829

1507. Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, et al. (2010). Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet. 42(5):406–9. PMID:20400963

1508. Venable JG, Schwartz AM, Silverberg SG (1990). Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity. Hum Pathol. 21(3):333–8. PMID:2312110

1509. Venkitaraman AR (2009). Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol. 4:461–87. PMID:18954285

1510. Vera-Sempere F, Llombart-Bosch A (1985). Lipid-rich versus lipid-secreting carcinoma of the mammary gland. Pathol Res Pract. 180(5):553–8. PMID:4080639

1511. Vergier B, Trojani M, de Mascarel I, Coindre JM, Le Treut A (1991). Metastases to the breast: differential diagnosis from primary breast carcinoma. J Surg Oncol. 48(2):112–6. PMID:1921396

1512. Vermeulen PB, van Golen KL, Dirix LY (2010). Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer. 116(11) Suppl:2748–54. PMID:20503405

1513. Viacava P, Naccarato AG, Nardini V, Bevilacqua G (1995). Breast carcinoma with osteoclast-like giant cells: immunohistochemical and ultrastructural study of a case and review of the literature. Tumori. 81(2):135–41. PMID:7778217

1514. Viale G, Rotmensz N, Maisonneuve P, Orvieto E, Maiorano E, Galimberti V, et al. (2009). Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat. 117(1):211–4. PMID:18629634

1515. Vieira CC, Mercado CL, Cangiarella JF, Moy L, Toth HK, Guth AA (2010). Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol. 73(1):102–7. PMID:19026501

1516. Vielh P, Validire P, Kheirallah S, Campana F, Fourquet A, Di Bonito L (1993). Paget’s disease of the nipple without clinically and radiologically detectable breast tumor. Histochemical and immunohistochemical study of 44 cases. Pathol Res Pract. 189(2):150–5. PMID:8391688

1517. Villa MT, White LE, Petronic-Rosic V, Song DH (2008). The treatment of diffuse dermal angiomatosis of the breast with reduction mammaplasty. Arch Dermatol. 144(5):693–4. PMID:18490610

1518. Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, et al. (2011). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol. 12(6):559–67. PMID:21601526

1519. Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, et al. (2007). Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res. 9(2):R24. PMID:17417968

1520. Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, Goudefroye R, et al.; breast cancer study group of the Institut Curie (2008). Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clin Cancer Res. 14(7):1956–65. PMID:18381933

1521. Vinh-Hung V, Burzykowski T, Cserni G, Voordeckers M, Van De Steene J, Storme G (2003). Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol. 22(3):697–704. PMID:12579326

1522. Vinh-Hung V, Nguyen NP, Cserni G, Truong P, Woodward W, Verkooijen HM, et al. (2009). Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol. 5(10):1585–603. PMID:20001797

1523. Virk RK, Khan A (2010). Pseudoangiomatous stromal hyperplasia: an overview. Arch Pathol Lab Med. 134(7):1070–4. PMID:20586640

1524. Visscher DW, Pankratz VS, Santisteban M, Reynolds C, Ristimäki A, Vierkant RA, et al. (2008). Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst. 100(6):421–7. PMID:18334709

1525. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, et al. (2007). Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg. 194(4):527–31. PMID:17826073

1526. Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, et al. (2006). Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg. 192(4):552–5. PMID:16978974

1527. Vollebergh MA, Lips EH, Nederlof PM, Wessels LF, Schmidt MK, van Beers EH, et al. (2011). An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients. Ann Oncol. 22(7):1561–70. PMID:21135055

1528. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, et al. (1997). E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 76(9):1131–3. PMID:9365159

1529. Vourtsi A, Zervoudis S, Pafiti A, Athanasiadis S (2006). Male breast hemangioma–a rare entity: a case report and review of the literature. Breast J. 12(3):260–2. PMID:16684325

1530. Vranić S, Bilalović N, Lee LM, Kruslin B, Lilleberg SL, Gatalica Z (2007). PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney. Hum Pathol. 38(9):1425–31. PMID:17669465

1531. Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, et al. (2010). Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification. Hum Pathol. 41(11):1617–23. PMID:20688355

1532. Vranic S, Gatalica Z, Deng H, Frkovic-Grazio S, Lee LM, Gurjeva O, et al. (2011). ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast. J Clin Pathol. 64(1):54–7. PMID:21045236

1533. Vranic S, Gatalica Z, Deng H, Frkovic-Grazio S, Lee LM, Gurjeva O, et al. (2011). ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast. J Clin Pathol. 64(1):54–7. PMID:21045236

1534. Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG (2005). Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys. 62(4):1040–7. PMID:15990007

1535. Vuitch MF, Rosen PP, Erlandson RA (1986). Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol. 17(2):185–91. PMID:3949338

1536. Waddell N, Arnold J, Cocciardi S, da Silva L, Marsh A, Riley J, et al.; kConFab Investigators (2010). Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res Treat. 123(3):661–77. PMID:19960244

1537. Waddell N, Jonnalagadda J, Marsh A, Grist S, Jenkins M, Hobson K, et al.; kConFab Investigators (2006). Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling. Genes Chromosomes Cancer. 45(12):1169–81. PMID:17001622

1538. Wahner-Roedler DL, Sebo TJ, Gisvold JJ (2001). Hamartomas of the breast: clinical, radiologic, and pathologic manifestations. Breast J. 7(2):101–5. PMID:11328316

1539. Waite KA, Eng C (2002). Protean PTEN: form and function. Am J Hum Genet. 70(4):829–44. PMID:11875759

1540. Waldman FM, Hwang ES, Etzell J, Eng C, DeVries S, Bennington J, et al. (2001). Genomic alterations in tubular breast carcinomas. Hum Pathol. 32(2):222–6. PMID:11230710

1541. Walford N, ten Velden J (1989). Histiocytoid breast carcinoma: an apocrine variant of lobular carcinoma. Histopathology. 14(5):515–22. PMID:2472346

1542. Wallis M, Tardivon A, Helbich T, Schreer I; European Society of Breast Imaging (2007). Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures. Eur Radiol. 17(2):581–8. PMID:17013595

1543. Walsh MD, Buchanan DD, Cummings MC, Pearson SA, Arnold ST, Clendenning M, et al. (2010). Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 16(7):2214–24. PMID:20215533

1544. Walsh MM, Bleiweiss IJ (2001). Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 32(6):583–9. PMID:11431712

1545. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, et al. (2006). Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA. 295(12):1379–88. PMID:16551709

1546. Wang H, Ge J, Chen L, Xie P, Chen F, Chen Y (2009). Melanocytic malignant peripheral nerve sheath tumor of the male breast. Breast Care (Basel). 4(4):260–2. PMID:20877665

1547. Wang N, Leeming R, Abdul-Karim FW (2004). Fine needle aspiration cytology of breast cylindroma in a woman with familial cylindromatosis: a case report. Acta Cytol. 48(6):853–8. PMID:15581173

1548. Wang W (2007). Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 8(10):735–48. PMID:17768402

1549. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 365(9460):671–9. PMID:15721472

1550. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al. (2011). Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 103(6):478–88. PMID:21398619

1551. Ward BA, McKhann CF, Ravikumar TS (1992). Ten-year follow-up of breast carcinoma in situ in Connecticut. Arch Surg. 127(12):1392–5. PMID:1365682

1551A. Wargotz ES, Deos PH, Norris HJ (1989). Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol. 20(8):732–40. PMID:2473024

1551B. Wargotz ES, Norris HJ (1989). Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol. 20(7):628–35. PMID:2544506

1551C. Wargotz ES, Norris HJ (1989). Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer. 64(7):1490–9. PMID:2776108

1551D. Wargotz ES, Norris HJ (1990). Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer. 65(2):272–6. PMID:2153044

1552. Wargotz ES, Norris HJ (1990). Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol. 21(11):1142–50. PMID:2227922

1553. Wargotz ES, Norris HJ, Austin RM, Enzinger FM (1987). Fibromatosis of the breast. A clinical and pathological study of 28 cases. Am J Surg Pathol. 11(1):38–45. PMID:3789257

1554. Wargotz ES, Weiss SW, Norris HJ (1987). Myofibroblastoma of the breast. Sixteen cases of a distinctive benign mesenchymal tumor. Am J Surg Pathol. 11(7):493–502. PMID:3037930

1555. Warner NE (1969). Lobular carcinoma of the breast. Cancer. 23(4):840–6. PMID:5775975

1556. Watermann DO, Tempfer C, Hefler LA, Parat C, Stickeler E (2005). Ultrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer. Ultrasound Med Biol. 31(2):167–74. PMID:15708454

1557. Watson CM, Davison AN, Baker D, O’Neill JK, Turk JL (1991). Suppression of demyelination by mitoxantrone. Int J Immunopharmacol. 13(7):923–30. PMID:1761358

1558. Watson P, Lynch HT (2001). Cancer risk in mismatch repair gene mutation carriers. Fam Cancer. 1(1):57–60. PMID:14574017

1559. Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Järvinen HJ, et al. (2008). The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer. 123(2):444–9. PMID:18398828

1560. Weaver DL (2010). Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale. Mod Pathol. 23 Suppl 2:S26–32. PMID:20436499

1561. Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, et al. (2011). Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med. 364(5):412–21. PMID:21247310

1562. Weaver DL, Le UP, Dupuis SL, Weaver KA, Harlow SP, Ashikaga T, et al. (2009). Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. Am J Surg Pathol. 33(11):1583–9. PMID:19730364

1563. Weaver J, Billings SD (2009). Postradiation cutaneous vascular tumors of the breast: a review. Semin Diagn Pathol. 26(3):141–9. PMID:20043513

1564. Weaver MG, Abdul-Karim FW, al-Kaisi N (1993). Mucinous lesions of the breast. A pathological continuum. Pathol Res Pract. 189(8):873–6. PMID:8302709

1565. Weidner N, Semple JP (1992). Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol. 23(10):1167–71. PMID:1398644

1566. Weigelt B, Baehner FL, Reis-Filho JS (2010). The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol. 220(2):263–80. PMID:19927298

1567. Weigelt B, Geyer FC, Horlings HM, Kreike B, Halfwerk H, Reis-Filho JS (2009). Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type. Mod Pathol. 22(11):1401–14. PMID:19633645

1568. Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K, et al. (2010). The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol. 220(1):45–57. PMID:19877120

1569. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. (2008). Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 216(2):141–50. PMID:18720457

1569A. Weigelt B, Mackay A, A’hern R, Natrajan R, Tan DS, Dowsett M, et al. (2010). Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 11(4):339–49. PMID:20181526

1569B. Weigelt B, Kreike B, Reis-Filho JS (2009). Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat. 117(2):273–80. PMID:18815879

1569C. Weigelt B, Reis-Filho JS (2009). Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol. 6(12):718–30. PMID:19942925

1570. Weiss JR, Moysich KB, Swede H (2005). Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev. 14(1):20–6. PMID:15668471

1571. Weiss SW, Nickoloff BJ (1993). CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol. 17(10):1039–45. PMID:7690524

1572. Weitzel JN, Pooler PA, Mohammed R, Levitt MD, Eckfeldt JH (1988). A unique case of breast carcinoma producing pancreatic-type isoamylase. Gastroenterology. 94(2):519–20. PMID:2446952

1573. Wellings SR, Jensen HM, Marcum RG (1975). An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 55(2):231–73. PMID:169369

1574. Wells CA, Ferguson DJ (1988). Ultrastructural and immunocytochemical study of a case of invasive cribriform breast carcinoma. J Clin Pathol. 41(1):17–20. PMID:3343375

1574A. Wells CA, Wells CW, Yeomans P, Viña M, Jordan S, d’Ardenne AJ (1990). Spherical connective tissue inclusions in epithelial hyperplasia of the breast (“collagenous spherulosis”). J Clin Pathol. 43(11):905–8. PMID:2262560

1575. Wessels LF, van Welsem T, Hart AA, van’t Veer LJ, Reinders MJ, Nederlof PM (2002). Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Cancer Res. 62(23):7110–7. PMID:12460933

1576. Westenend PJ, Schütte R, Hoogmans MM, Wagner A, Dinjens WN (2005). Breast cancer in an MSH2 gene mutation carrier. Hum Pathol. 36(12):1322–6. PMID:16311127

1577. Weston VJ, Oldreive CE, Skowronska A, Oscier DG, Pratt G, Dyer MJ, et al. (2010). The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood. 116(22):4578–87. PMID:20739657

1577A. Wetterskog D, Lopez-Garcia MA, Lambros MB, A’Hern R, Geyer FC, Milanezi F, et al. (2012). Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol. 226(1):84–96. PMID:22015727

1578. White RR, Halperin TJ, Olson JA Jr, Soo MS, Bentley RC, Seigler HF (2001). Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg. 233(6):769–77. PMID:11371735

1579. Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, et al. (2004). Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev. 13(12):2078–83. PMID:15598764

1580. Whitten TM, Wallace TW, Bird RE, Turk PS (1997). Image-guided core biopsy has advantages over needle localization biopsy for the diagnosis of nonpalpable breast cancer. Am Surg. 63(12):1072–7, discussion 1077–8. PMID:9393255

1581. Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, et al. (2009). Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol. 16(10):2705–10. PMID:19593632

1582. Wijnen J, Khan PM, Vasen H, van der Klift H, Mulder A, van Leeuwen-Cornelisse I, et al. (1997). Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet. 61(2):329–35. PMID:9311737

1583. Willemze R, Swerdlow SH, Harris NL, Vergier B (2008). Primary cutaneous follicle centre lymphoma. In: WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edition.Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H et al. IARC: Lyon: pp 227–228.

1584. Williams SA, Ehlers RA 2nd, Hunt KK, Yi M, Kuerer HM, Singletary SE, et al. (2007). Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer. 110(4):731–7. PMID:17582626

1585. Wilson JR, Bateman AC, Hanson H, An Q, Evans G, Rahman N, et al. (2010). A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet. 47(11):771–4. PMID:20805372

1586. Wimmer K, Etzler J (2008). Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet. 124(2):105–22. PMID:18709565

1587. Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP (1998). A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg. 186(4):416–22. PMID:9544955

1588. Winnes M, Mölne L, Suurküla M, Andrén Y, Persson F, Enlund F, et al. (2007). Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes Chromosomes Cancer. 46(6):559–63. PMID:17334997

1589. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. (2008). Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 10(4):R65. PMID:18662380

1590. Wiseman C, Liao KT (1972). Primary lymphoma of the breast. Cancer. 29(6):1705–12. PMID:4555557

1591. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al.; American Society of Clinical Oncology; College of American Pathologists (2007). American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 25(1):118–45. PMID:17159189

1592. Wong AK, Lopategui J, Clancy S, Kulber D, Bose S (2008). Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol. 32(8):1265–8. PMID:18594466

1593. Wong AY, Salisbury E, Bilous M (2000). Recent developments in stereotactic breast biopsy methodologies: an update for the surgical pathologist. Adv Anat Pathol. 7(1):26–35. PMID:10640199

1594. Wood B, Sterrett G, Frost F, Swarbrick N (2008). Diagnosis of extramammary malignancy metastatic to the breast by fine needle biopsy. Pathology. 40(4):345–51. PMID:18446623

1594A. Woodard BH, Brinkhous AD, McCarty KS Sr, McCarty KS Jr (1980). Adenosquamous differentiation in mammary carcinoma: an ultrastructural and steroid receptor study. Arch Pathol Lab Med. 104(3):130–3. PMID:6892594

1595. Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR, et al. (2007). A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat. 28(7):669–73. PMID:17347989

1596. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, et al. (2006). Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 24(18):2910–6. PMID:16782931

1597. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature. 378(6559):789–92. PMID:8524414

1598. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science. 265(5181):2088–90. PMID:8091231

1599. World Cancer Research Fund (2007). Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington (DC): AICR.

1599A. World Health Organization (1981). Histological typing of breast tumours: international histological classification of tumours. 2nd ed. Geneva: WHO.

1600. Wrba F, Ellinger A, Reiner G, Spona J, Holzner JH (1988). Ultrastructural and immunohistochemical characteristics of lipid-rich carcinoma of the breast. Virchows Arch A Pathol Anat Histopathol. 413(5):381–5. PMID:2845641

1601. Wu CC, Krahe R, Lozano G, Zhang B, Wilson CD, Jo EJ, et al. (2011). Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Hum Genet. 129(6):663–73. PMID:21305319

1602. Xiao Y, Ye Y, Zou X, Jones S, Yearsley K, Shetuni B, et al. (2011). The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction. Oncogene. 30(3):287–300. PMID:20838375

1603. Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, et al. (2010). Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol. 40(8):781–7. PMID:20444748

1604. Yang H, Ahmed I, Mathew V, Schroeter AL (2006). Diffuse dermal angiomatosis of the breast. Arch Dermatol. 142(3):343–7. PMID:16549710

1605. Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thoma NH, et al. (2002). BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science. 297(5588):1837–48. PMID:12228710

1606. Yang M, Moriya T, Oguma M, De La Cruz C, Endoh M, Ishida T, et al. (2003). Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Pathol Int. 53(7):422–8. PMID:12828606

1607. Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK, et al. (2002). Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 52(5):1231–7. PMID:11955733

1608. Yilmaz E, Sal S, Lebe B (2002). Differentiation of phyllodes tumors versus fibroadenomas. Acta Radiol. 43(1):34–9. PMID:11972459

1609. Yoo JL, Woo OH, Kim YK, Cho KR, Yong HS, Seo BK, et al. (2010). Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas? Radiographics. 30(6):1689–702. PMID:21071383

1609A. Yorozuya K, Takeuchi T, Yoshida M, Mouri Y, Kousaka J, Fujii K, et al. (2010). Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer. J Cancer Res Clin Oncol. 136(6):939–44. PMID:19946706

1610. Yoshida S, Nakamura N, Sasaki Y, Yoshida S, Yasuda M, Sagara H, et al. (2005). Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Mod Pathol. 18(3):398–405. PMID:15492762

1611. Young RH, Clement PB (1988). Adenomyoepithelioma of the breast. A report of three cases and review of the literature. Am J Clin Pathol. 89(3):308–14. PMID:2831705

1612. Youngson BJ, Cranor M, Rosen PP (1994). Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol. 18(9):896–903. PMID:8067510

1613. Yu GH, Fishman SJ, Brooks JS (1993). Cellular angiolipoma of the breast. Mod Pathol. 6(4):497–9. PMID:8415599

1614. Yu JI, Choi DH, Park W, Huh SJ, Cho EY, Lim YH, et al. (2010). Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study. Breast. 19(3):231–7. PMID:20304650

1615. Yu K, Lee CH, Tan PH, Hong GS, Wee SB, Wong CY, et al. (2004). A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res. 64(9):2962–8. PMID:15126326

1616. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC (2000). Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer. 85(3):364–9. PMID:10652428

1617. Zafrani B, Aubriot MH, Mouret E, De Crémoux P, De Rycke Y, Nicolas A, et al. (2000). High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Histopathology. 37(6):536–45. PMID:11122436

1618. Zakaria S, Pantvaidya G, Ghosh K, Degnim AC (2007). Paget’s disease of the breast: accuracy of preoperative assessment. Breast Cancer Res Treat. 102(2):137–42. PMID:17028984

1619. Zaloudek C, Oertel YC, Orenstein JM (1984). Adenoid cystic carcinoma of the breast. Am J Clin Pathol. 81(3):297–307. PMID:6322567

1620. Zamecnik M, Michal M, Gogora M, Mukensnabl P, Dobias V, Vano M (2002). Gynecomastia with pseudoangiomatous stromal hyperplasia and multinucleated giant cells. Association with neurofibromatosis type 1. Virchows Arch. 441(1):85–7. PMID:12111205

1621. Zandrino F, Calabrese M, Faedda C, Musante F (2006). Tubular carcinoma of the breast: pathological, clinical, and ultrasonographic findings. A review of the literature. Radiol Med. 111(6):773–82. PMID:16896563

1622. Zekioglu O, Erhan Y, Ciris M, Bayramoglu H, Ozdemir N (2004). Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology. 44(1):18–23. PMID:14717664

1623. Zhang S, Phelan CM, Zhang P, Rousseau F, Ghadirian P, Robidoux A, et al. (2008). Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. Cancer Res. 68(7):2154–7. PMID:18381420

1624. Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, et al. (2003). Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst. 95(5):373–80. PMID:12618502

1625. Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, et al. (2004). Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell. 15(6):2523–36. PMID:15034139

1626. Zhao J, Lang R, Guo X, Chen L, Gu F, Fan Y, et al. (2010). Clinicopathologic characteristics of pleomorphic carcinoma of the breast. Virchows Arch. 456(1):31–7. PMID:20013346

1626A. Zelek L, Llombart-Cussac A, Terrier P, Pivot X, Guinebretiere JM, Le Pechoux C, et al. (2003). Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol. 21(13):2583–8. PMID:12829679

1626B. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. (2009). Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 41(3):324–8. PMID:19219042

1627. Zhou X, Hampel H, Thiele H, Gorlin RJ, Hennekam RC, Parisi M, et al. (2001). Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet. 358(9277):210–1. PMID:11476841

1628. Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, et al. (2003). Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet. 73(2):404–11. PMID:12844284

1629. Ziegler RG, Hoover RN, Nomura AM, West DW, Wu AH, Pike MC, et al. (1996). Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst. 88(10):650–60. PMID:8627641

1630. Zou D, Yoon HS, Perez D, Weeks RJ, Guilford P, Humar B (2009). Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia. J Pathol. 218(2):265–72. PMID:19294736

1631. Zúbor P, Kajo K, Dussan CA, Szunyogh N, Danko J (2006). Rapidly growing nodular pseudoangiomatous stromal hyperplasia of the breast in an 18-year-old girl. APMIS. 114(5):389–92. PMID:16725017